Longitudinal Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 13, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Lior Carmon1,2, Majd Nassar1,2, Daphna Idan2
1Pediatrics Endocrinology Unit, Saban Children's Hospital, Soroka University Medical Center, Beer-Sheva 8410501, Israel.
Enzyme replacement therapy (ERT) with Elosulfase alfa did not prevent height loss in Mucopolysaccharidoses (MPS) IVA patients. Growth trajectories in MPS IVA and MPS IIIA show distinct patterns, with ERT not significantly altering height decline rates.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: